The mechanisms of delayed onset type adverse reactions to oseltamivir

Intravenous peramivir inhibits viral replication, and leads to bacterial clearance and prevention of mortality during murine bacterial co-infection caused by influenza A(H1N1)pdm09 virus and Streptococcus pneumoniae

(2015) Motoyasu Onishi et al.   ANTIVIRAL RESEARCH

The administration of oseltamivir results in reduced effector and memory CD8+ T cell responses to influenza and affects protective immunity

(2015) Isabelle Marois et al.   FASEB JOURNAL

The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice

(2014) Akitaka Tanaka et al.   ANTIVIRAL THERAPY

Oseltamivir Blocks Human Neuronal Nicotinic Acetylcholine Receptor-Mediated Currents

(2014) Katsuhiko Muraki et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Efficacy of Repeated Intravenous Injection of Peramivir against Influenza A (H1N1) 2009 Virus Infection in Immunosuppressed Mice

(2013) Mitsutaka Kitano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inhibition of MAO-A and stimulation of behavioural activities in mice by the inactive prodrug form of the anti-influenza agent oseltamivir

(2013) Miki Hiasa et al.   BRITISH JOURNAL OF PHARMACOLOGY

Immunomodulator Clarithromycin Enhances Mucosal and Systemic Immune Responses and Reduces Re-Infection Rate in Pediatric Patients with Influenza Treated with Antiviral Neuraminidase Inhibitors: A Retrospective Analysis

(2013) Wakako Shinahara et al.   PLoS One

Oral Clarithromycin Enhances Airway Immunoglobulin A (IgA) Immunity through Induction of IgA Class Switching Recombination and B-Cell-Activating Factor of the Tumor Necrosis Factor Family Molecule on Mucosal Dendritic Cells in Mice Infected with Influenza A Virus

(2012) E. Takahashi et al.   JOURNAL OF VIROLOGY

Zanamivir Pharmacokinetics and Pulmonary Penetration into Epithelial Lining Fluid following Intravenous or Oral Inhaled Administration to Healthy Adult Subjects

(2011) Mark J. Shelton et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Phase III Randomized, Double-Blind Study Comparing Single-Dose Intravenous Peramivir with Oral Oseltamivir in Patients with Seasonal Influenza Virus Infection

(2011) Shigeru Kohno et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Oseltamivir treatment of mice before or after mild influenza infection reduced cellular and cytokine inflammation in the lung

(2011) Zi Xin Wong et al.   Influenza and Other Respiratory Viruses

Endogenous PMN sialidase activity exposes activation epitope on CD11b/CD18 which enhances its binding interaction with ICAM-1

(2011) Chiguang Feng et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Long-Acting Neuraminidase Inhibitor Laninamivir Octanoate (CS-8958) versus Oseltamivir as Treatment for Children with Influenza Virus Infection

(2010) N. Sugaya et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity

(2010) Nicholas M. Stamatos et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Attenuation of inducible respiratory immune responses by oseltamivir treatment in mice infected with influenza A virus

(2010) Etsuhisa Takahashi et al.   MICROBES AND INFECTION

In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu®) and active metabolite

(2009) Lothar Lindemann et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Synaptic and behavioral interactions of oseltamivir (Tamiflu) with neurostimulants

(2009) Y Izumi et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Boost of mucosal secretory immunoglobulin A response by clarithromycin in paediatric influenza

(2009) Takako SAWABUCHI et al.   RESPIROLOGY

Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?

(2008) Frederick Hayden   CLINICAL INFECTIOUS DISEASES